Back to
MORGAN STANLEY
BBNX6 quarters
Position history for
MORGAN STANLEY's holdings in BETA BIONICS INC
Yes. Morgan Stanley holds 4,266,822 shares of BBNX (Beta Bionics), worth $66.9M, as of its Q2 2026 13F filing. It increased the position by 39,188 shares (+0.9%) from Q1 2026. Morgan Stanley has held BBNX in every 13F on record since Q1 2025, 6 quarterly filings.
Current Value
$66.9M
Current Shares
4.3M
Total Value Change
+$49.7M
Total Shares Change
+2.9M
Quarter-by-Quarter History
Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP